NCT02036372View on ClinicalTrials.gov

Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Diabetes Mellitus Type II
Interventions
DRUG

Liraglutide

DRUG

Insulin bolus

DRUG

GIK infusion

continuous infusion

Trial Locations (3)

1105AZ

Academic Medical Center Amsterdam, Amsterdam

Unknown

Onze Lieve Vrouwe Gasthuis, Amsterdam

3582 KE

Diakonessenhuis, Utrecht

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02036372 - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus | Biotech Hunter | Biotech Hunter